Biological E gets DCGI nod for Phase 3 clinical trials of Corbevax as booster dose
Amid the sudden surge in COVID-19 cases due to Omicron and the need for booster doses for better protection, Biological E…
THE VOICE OF THE YOUTH
Amid the sudden surge in COVID-19 cases due to Omicron and the need for booster doses for better protection, Biological E…
The Centre has rejected the Pune-based Serum Institute of India’s (SII) request to approve the third dose of Covishield even…